Cardlytics Inc.
12/05/2025 | Press release | Distributed by Public on 12/05/2025 07:04
Management Change/Compensation (Form 8-K)
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
On December 3, 2025, Alexis DeSieno, the Company's Chief Financial Officer, notified the Company of her intent to resign as Chief Financial Officer, effective as of the earlier of the appointment of her successor or the close of business on March 6, 2026. Ms. DeSieno's resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices or the Company's financial statements or internal controls over financial reporting. The Company has begun the process of identifying candidates for the Chief Financial Officer role.
In the event Ms. DeSieno's successor is appointed prior to March 6, 2026, the Company expects that Ms. DeSieno will remain employed in a non-officer advisory role through March 6, 2026, primarily focused on transitioning her responsibilities. Through the date her employment ends, Ms. DeSieno will continue to receive her current base salary and benefits.
The Company thanks Ms. DeSieno for her dedication and hard work over the last several years, including her efforts to help improve the Company's balance sheet and liquidity and optimize the Company's cost structure.
Cardlytics Inc. published this content on December 05, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on December 05, 2025 at 13:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]